| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MXI1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | TMEM156 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | TIMMDC1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | CDKN1B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | TMEM232 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | SLF2 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | GOT1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | NANOGNB | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | CEP170B | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | TNFRSF10D | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
